Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04244552 |
Title | First-in-Human Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Atreca, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |